Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization.
Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P. Damås JK, et al. Among authors: kjekshus j. Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):614-20. doi: 10.1161/01.ATV.0000255581.38523.7c. Epub 2006 Dec 14. Arterioscler Thromb Vasc Biol. 2007. PMID: 17170367
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure.
Yndestad A, Finsen AV, Ueland T, Husberg C, Dahl CP, Øie E, Vinge LE, Sjaastad I, Sandanger Ø, Ranheim T, Dickstein K, Kjekshus J, Damås JK, Fiane AE, Hilfiker-Kleiner D, Lipp M, Gullestad L, Christensen G, Aukrust P. Yndestad A, et al. Among authors: kjekshus j. PLoS One. 2012;7(3):e33038. doi: 10.1371/journal.pone.0033038. Epub 2012 Mar 12. PLoS One. 2012. PMID: 22427939 Free PMC article.
CXC-chemokines in coronary artery disease: possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells.
Holm T, Damås JK, Holven K, Nordøy I, Brosstad FR, Ueland T, Währe T, Kjekshus J, Frøland SS, Eiken HG, Solum NO, Gullestad L, Nenseter M, Aukrust P. Holm T, et al. Among authors: kjekshus j. J Thromb Haemost. 2003 Feb;1(2):257-62. doi: 10.1046/j.1538-7836.2003.00065.x. J Thromb Haemost. 2003. PMID: 12871498 Free article.
Soluble CD40 ligand in acute and chronic heart failure.
Ueland T, Aukrust P, Yndestad A, Otterdal K, Frøland SS, Dickstein K, Kjekshus J, Gullestad L, Damås JK. Ueland T, et al. Among authors: kjekshus j. Eur Heart J. 2005 Jun;26(11):1101-7. doi: 10.1093/eurheartj/ehi132. Epub 2005 Feb 16. Eur Heart J. 2005. PMID: 15716285 Clinical Trial.
Agents targeting inflammation in heart failure.
Gullestad L, Kjekshus J, Damås JK, Ueland T, Yndestad A, Aukrust P. Gullestad L, et al. Among authors: kjekshus j. Expert Opin Investig Drugs. 2005 May;14(5):557-66. doi: 10.1517/13543784.14.5.557. Expert Opin Investig Drugs. 2005. PMID: 15926863 Review.
Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study.
Gullestad L, Ueland T, Fjeld JG, Holt E, Gundersen T, Breivik K, Følling M, Hodt A, Skårdal R, Kjekshus J, Andreassen A, Kjekshus E, Wergeland R, Yndestad A, Frøland SS, Semb AG, Aukrust P. Gullestad L, et al. Among authors: kjekshus j, kjekshus e. Circulation. 2005 Nov 29;112(22):3408-14. doi: 10.1161/CIRCULATIONAHA.105.564971. Epub 2005 Nov 21. Circulation. 2005. PMID: 16301340 Clinical Trial.
CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.
Ueland T, Nymo SH, Latini R, McMurray JJ, Kjekshus J, Yndestad A, Fucili A, Grosu A, Masson S, Maggioni AP, Gullestad L, Aukrust P; Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) trial; Investigators of the GISSI-Heart Failure (GISSI-HF) trial. Ueland T, et al. Among authors: kjekshus j. Eur J Heart Fail. 2013 Jul;15(7):747-55. doi: 10.1093/eurjhf/hft031. Epub 2013 Mar 13. Eur J Heart Fail. 2013. PMID: 23487539 Free article. Clinical Trial.
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients.
Ueland T, Kjekshus J, Frøland SS, Omland T, Squire IB, Gullestad L, Dickstein K, Aukrust P. Ueland T, et al. Among authors: kjekshus j. J Am Coll Cardiol. 2005 Dec 6;46(11):2018-21. doi: 10.1016/j.jacc.2005.08.039. Epub 2005 Nov 9. J Am Coll Cardiol. 2005. PMID: 16325035 Free article.
361 results